文献速递神经MR

钆基对比剂经脑类淋巴通路:被忽视与误读的现象

Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain: Overlooked and Misinterpreted.
PubMed 文献 · Invest Radiol · 2019-01-01

本研究纳入33例神经健康患者和7例因脑转移导致血脑屏障受损的患者,在静脉注射钆基对比剂前、后3小时和24小时行重T2加权FLAIR成像,发现延迟成像可显示对比剂经脉络丛和睫状体进入中枢神经系统,并沿颅神经神经鞘和穿皮质动脉血管周围间隙引流;血管周围间隙信号增高与Fazekas评分在注射后3小时呈正相关。

要点

  • 延迟重T2加权FLAIR可显示钆对比剂经类淋巴系统进入和引流。
  • 类淋巴系统内钆对比剂可能属于自然排泄过程,不应与钆沉积混淆。
  • 深部白质高信号与类淋巴系统功能相关,提示可利用该通路进行诊断。

核心结论

  • 延迟T2加权钆增强成像可显示钆基对比剂进入并穿过类淋巴系统的通路;类淋巴系统内出现钆对比剂可能应视为自然排泄过程的一部分,不应与钆沉积混淆;深部白质高信号(血管性痴呆的影像征象)与类淋巴系统功能之间的相关性表明,利用钆对比剂经类淋巴系统的通路进行诊断具有可行性。

研究设计与样本

  • 探索性研究,纳入33例神经健康患者和7例因脑转移导致血脑屏障受损的患者,在静脉注射钆基对比剂前、注射后3小时和24小时行重T2加权液体衰减反转恢复(hT2w-FLAIR)磁共振成像,测定各脑脊液间隙信号强度,并采用Fazekas评分系统量化白质高信号。

关键影像表现/征象

  • 延迟hT2w-FLAIR显示钆基对比剂经脉络丛和睫状体进入中枢神经系统。
  • 钆基对比剂沿颅神经神经鞘和穿皮质动脉血管周围间隙引流。
  • 所有患者所有部位在3小时和24小时时间点信号强度较基线均显著增高。
  • 神经健康患者与血脑屏障受损患者之间信号强度无显著差异。
  • 注射后3小时血管周围间隙信号强度增高与Fazekas评分呈显著正相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The "glymphatic system" (GS), a brain-wide network of cerebrospinal fluid microcirculation, supplies a pathway through and out of the central nervous system (CNS); malfunction of the system is implicated in a variety of neurological disorders. In this exploratory study, we analyzed the potential of a new imaging approach that we coined delayed T2-weighted gadolinium-enhanced imaging to visualize the GS in vivo.

METHODS: Heavily T2-weighted fluid-attenuated inversion recovery (hT2w-FLAIR) magnetic resonance imaging was obtained before, and 3 hours and 24 hours after intravenous gadolinium-based contrast agent (GBCA) application in 33 neurologically healthy patients and 7 patients with an impaired blood-brain barrier (BBB) due to cerebral metastases. Signal intensity (SI) was determined in various cerebral fluid spaces, and white matter hyperintensities were quantified by applying the Fazekas scoring system.

FINDINGS: Delayed hT2w-FLAIR showed GBCA entry into the CNS via the choroid plexus and the ciliary body, with GBCA drainage along perineural sheaths of cranial nerves and along perivascular spaces of penetrating cortical arteries. In all patients and all sites, a significant SI increase was found for the 3 hours and 24 hours time points compared with baseline. Although no significant difference in SI was found between neurologically healthy patients and patients with an impaired BBB, a significant positive correlation between Fazekas scoring system and SI increase in the perivascular spaces 3 hours post injection was shown.

INTERPRETATION: Delayed T2-weighted gadolinium-enhanced imaging can visualize the GBCA pathway into and through the GS. Presence of GBCAs within the GS might be regarded as part of the natural excretion process and should not be mixed up with gadolinium deposition. Rather, the correlation found between deep white matter hyperintensities, an imaging sign of vascular dementia, and GS functioning demonstrated feasibility to exploit the pathway of GBCAs through the GS for diagnostic purposes.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Deike-Hofmann K, Reuter J, Haase R, et al. Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain: Overlooked and Misinterpreted. Invest Radiol. 2019. PMID: 30480554. doi:10.1097/RLI.0000000000000533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。